Cargando…

Association between different acute stroke therapies and development of post stroke seizures

BACKGROUND: Epilepsy is a major complication of stroke. We aimed to establish whether there is an association between intravenous thrombolysis, intra-arterial thrombolysis and post stroke seizure (PSS) development. Improved understanding of the relationship between reperfusion therapies and seizure...

Descripción completa

Detalles Bibliográficos
Autores principales: Naylor, Jillian, Thevathasan, Arthur, Churilov, Leonid, Guo, Ruibing, Xiong, Yunyun, Koome, Miriam, Chen, Ziyi, Chen, Ziyuan, Liu, Xinfeng, Kwan, Patrick, Campbell, Bruce C. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932812/
https://www.ncbi.nlm.nih.gov/pubmed/29724190
http://dx.doi.org/10.1186/s12883-018-1064-x
_version_ 1783319874124120064
author Naylor, Jillian
Thevathasan, Arthur
Churilov, Leonid
Guo, Ruibing
Xiong, Yunyun
Koome, Miriam
Chen, Ziyi
Chen, Ziyuan
Liu, Xinfeng
Kwan, Patrick
Campbell, Bruce C. V.
author_facet Naylor, Jillian
Thevathasan, Arthur
Churilov, Leonid
Guo, Ruibing
Xiong, Yunyun
Koome, Miriam
Chen, Ziyi
Chen, Ziyuan
Liu, Xinfeng
Kwan, Patrick
Campbell, Bruce C. V.
author_sort Naylor, Jillian
collection PubMed
description BACKGROUND: Epilepsy is a major complication of stroke. We aimed to establish whether there is an association between intravenous thrombolysis, intra-arterial thrombolysis and post stroke seizure (PSS) development. Improved understanding of the relationship between reperfusion therapies and seizure development may improve post-stroke monitoring and follow-up. METHODS: This was a retrospective, multicentre cohort study conducted at the Royal Melbourne Hospital and Jingling Hospital Nanjing. We included patients with anterior circulation ischemic stroke admitted 2008–2015. Patients were divided into four treatment groups 1. IV-tPA only, 2. Intra-arterial therapies (IAT) only, 3. IAT + IV-tPA and 4. stroke unit care only (i.e. no IV-tPA or IAT). To assess the association between type of reperfusion treatment and seizure incidence we used multivariable logistic regression models adjusted for age, stroke severity, 3-month functional outcome and prognostic factors. RESULTS: There were 1375 stroke unit care-only patients, of whom 28 (2%) developed PSS. There were 363 patients who received only IV-tPA, of whom 21 (5.8%) developed PSS. There were 93 patients who received IAT only, of whom 12 (12.9%) developed PSS and 112 that received both IV-tPA + IAT, of which 5 (4.5%) developed PSS. All reperfusion treatments were associated with seizure development compared to stroke unit care-only patients: IV-tPA only adjusted odds ratio (aOR) 3.7, 95%CI 1.8–7.4, p < 0.0001; IAT aOR 5.5, 95%CI 2.1–14.3, p < 0.0001, IAT + IV-tPA aOR 3.4, 95% CI 0.98–11.8, p = 0.05. These aORs did not differ significantly between treatment groups (IV-tPA + IAT versus IV-tPA p = 0.89, IV-tPA + IAT versus IAT, p = 0.44). CONCLUSIONS: Patients receiving thrombolytic or intra-arterial reperfusion therapies for acute ischemic stroke are at higher risk of epilepsy and may benefit from longer follow-up. No evidence for an additive or synergistic effect of treatment modality on seizure development was found. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-018-1064-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5932812
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59328122018-05-09 Association between different acute stroke therapies and development of post stroke seizures Naylor, Jillian Thevathasan, Arthur Churilov, Leonid Guo, Ruibing Xiong, Yunyun Koome, Miriam Chen, Ziyi Chen, Ziyuan Liu, Xinfeng Kwan, Patrick Campbell, Bruce C. V. BMC Neurol Research Article BACKGROUND: Epilepsy is a major complication of stroke. We aimed to establish whether there is an association between intravenous thrombolysis, intra-arterial thrombolysis and post stroke seizure (PSS) development. Improved understanding of the relationship between reperfusion therapies and seizure development may improve post-stroke monitoring and follow-up. METHODS: This was a retrospective, multicentre cohort study conducted at the Royal Melbourne Hospital and Jingling Hospital Nanjing. We included patients with anterior circulation ischemic stroke admitted 2008–2015. Patients were divided into four treatment groups 1. IV-tPA only, 2. Intra-arterial therapies (IAT) only, 3. IAT + IV-tPA and 4. stroke unit care only (i.e. no IV-tPA or IAT). To assess the association between type of reperfusion treatment and seizure incidence we used multivariable logistic regression models adjusted for age, stroke severity, 3-month functional outcome and prognostic factors. RESULTS: There were 1375 stroke unit care-only patients, of whom 28 (2%) developed PSS. There were 363 patients who received only IV-tPA, of whom 21 (5.8%) developed PSS. There were 93 patients who received IAT only, of whom 12 (12.9%) developed PSS and 112 that received both IV-tPA + IAT, of which 5 (4.5%) developed PSS. All reperfusion treatments were associated with seizure development compared to stroke unit care-only patients: IV-tPA only adjusted odds ratio (aOR) 3.7, 95%CI 1.8–7.4, p < 0.0001; IAT aOR 5.5, 95%CI 2.1–14.3, p < 0.0001, IAT + IV-tPA aOR 3.4, 95% CI 0.98–11.8, p = 0.05. These aORs did not differ significantly between treatment groups (IV-tPA + IAT versus IV-tPA p = 0.89, IV-tPA + IAT versus IAT, p = 0.44). CONCLUSIONS: Patients receiving thrombolytic or intra-arterial reperfusion therapies for acute ischemic stroke are at higher risk of epilepsy and may benefit from longer follow-up. No evidence for an additive or synergistic effect of treatment modality on seizure development was found. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-018-1064-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-03 /pmc/articles/PMC5932812/ /pubmed/29724190 http://dx.doi.org/10.1186/s12883-018-1064-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Naylor, Jillian
Thevathasan, Arthur
Churilov, Leonid
Guo, Ruibing
Xiong, Yunyun
Koome, Miriam
Chen, Ziyi
Chen, Ziyuan
Liu, Xinfeng
Kwan, Patrick
Campbell, Bruce C. V.
Association between different acute stroke therapies and development of post stroke seizures
title Association between different acute stroke therapies and development of post stroke seizures
title_full Association between different acute stroke therapies and development of post stroke seizures
title_fullStr Association between different acute stroke therapies and development of post stroke seizures
title_full_unstemmed Association between different acute stroke therapies and development of post stroke seizures
title_short Association between different acute stroke therapies and development of post stroke seizures
title_sort association between different acute stroke therapies and development of post stroke seizures
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932812/
https://www.ncbi.nlm.nih.gov/pubmed/29724190
http://dx.doi.org/10.1186/s12883-018-1064-x
work_keys_str_mv AT naylorjillian associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT thevathasanarthur associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT churilovleonid associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT guoruibing associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT xiongyunyun associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT koomemiriam associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT chenziyi associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT chenziyuan associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT liuxinfeng associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT kwanpatrick associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures
AT campbellbrucecv associationbetweendifferentacutestroketherapiesanddevelopmentofpoststrokeseizures